"10.1371_journal.pone.0072112","plos one","2013-08-16T00:00:00Z","Nassima Oumata; Phu hai Nguyen; Vincent Beringue; Flavie Soubigou; Yanhong Pang; Nathalie Desban; Catherine Massacrier; Yannis Morel; Carine Paturel; Marie-Astrid Contesse; Serge Bouaziz; Suparna Sanyal; Hervé Galons; Marc Blondel; Cécile Voisset","Laboratoire de Chimie Organique 2, INSERM U1022, Université Paris Descartes, Paris, France; Institut National de la Sante et de la recherche Medicale UMR1078, Université de Bretagne Occidentale, Faculté de Médecine et des Sciences de la Santé ; Etablissement Français du Sang (EFS) Bretagne ; CHRU Brest, Hôpital Morvan, Laboratoire de Génétique Moléculaire, Brest, France; Virologie Immunologie Moléculaires, UR892, Institut National de la Recherche Agronomique (INRA), Jouy-en-Josas, France; Department of Cell and Molecular Biology, BMC, Uppsala University, Uppsala, Sweden; Protein Phosphorylation & Disease Laboratory, CNRS UPS2682, Roscoff, France; Innate Pharma, Marseille, France; UMR 8015 CNRS, Laboratoire de Cristallographie et RMN Biologiques, Université Paris Descartes, Paris, France","Conceived and designed the experiments: MB CV HG VB YM CP. Performed the experiments: PN NO VB FS YP ND CM MAC CV SB. Analyzed the data: MB CV HG VB SS CP YM. Wrote the manuscript: CV MB HG VB SB.","CM, YM and CP are or were employed by Innate Pharma. The authors collaboration with Innate Pharma was based on their expertise on agonists of TLR7/8 receptors, and so the authors acknowledge their scientific and technical contributions by adding their names to the author list.  There are no patents, products in development or marketed products with Innate Pharma to declare.  This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2013","08","Nassima Oumata","NO",15,TRUE,6,10,7,5,TRUE,FALSE,FALSE,0,NA,FALSE
